In mid-January, President Donald Trump unveiled a new health care affordability framework, positioning it as a response to rising health care costs and mounting political pressure following the expiration of enhanced Affordable Care Act (ACA) premium subsidies. While still in its early stages and lacking legislative detail, the framework offers insight into how health care policy discussions may evolve in the months ahead.
Unlike prior reform efforts that focused heavily on expanding subsidies to insurers or strengthening government-sponsored coverage, this proposal emphasizes direct consumer control, market transparency, and competition. For employers—particularly those managing ACA compliance, association health plans, or alternative coverage structures—the framework may foreshadow meaningful structural shifts in the health insurance market.
A Shift Away From Expanded ACA Subsidies
One of the most notable aspects of the framework is what it omits. The proposal does not extend the enhanced ACA premium subsidies that expired at the end of 2024. Instead, it advances alternative approaches aimed at reducing premiums and out-of-pocket costs without increasing insurer-focused government support.
This marks a clear departure from recent health policy trends and suggests a broader philosophical shift: rather than reinforcing the ACA subsidy model, the framework seeks to empower individuals to make health care purchasing decisions more directly, with fewer intermediaries influencing cost structures.
Key Components of the Framework
While many details remain unresolved and would require congressional action, the framework outlines several core policy priorities that employers should monitor closely.
Redirecting subsidies to individuals.
Rather than funneling government health subsidies through insurance carriers, the proposal would direct assistance straight to individuals. Supporters argue that this could increase consumer choice and cost awareness, while critics note that implementation details—such as eligibility, distribution, and oversight—remain unclear.
Voluntary “most favored nation” drug pricing.
The framework proposes codifying voluntary arrangements that tie certain prescription drug prices to the lowest prices paid by other developed nations. While not mandatory, this approach reflects ongoing efforts to curb drug costs without imposing broad federal price controls.
Increased insurer transparency requirements.
Insurers would face new disclosure obligations related to claims denials, pricing structures, and administrative overhead. The stated goal is to provide consumers and employers with clearer insight into how premiums are set and how plan dollars are spent, potentially increasing accountability across the insurance market.
Targeting pharmacy benefit managers (PBMs).
The proposal also takes aim at PBM practices, particularly rebate structures that may inflate downstream costs. By limiting or restructuring these arrangements, the framework seeks to reduce pricing distortions that can affect both employer-sponsored and individual plans.
What This Could Mean for Employers
For employers, the framework’s significance lies less in its immediate legal impact and more in what it signals about the future direction of health care policy. If advanced, these proposals could reshape how coverage is priced, purchased, and regulated.
Employers that rely on traditional fully insured plans, association health plans, or alternative coverage models may see changes in carrier behavior, pricing transparency, or plan design options. Likewise, employers navigating ACA compliance should be aware that future regulatory adjustments could alter subsidy dynamics, enrollment incentives, or individual market participation.
Importantly, because the framework does not extend enhanced ACA subsidies, employers may also see renewed pressure on employees who rely on the individual marketplace for coverage—particularly if alternative affordability mechanisms are slow to materialize.
Looking Ahead
At this stage, the health care affordability framework is best understood as a policy signal rather than a finalized roadmap. Many elements would require legislative action, and political negotiations will likely shape whether—and how—any of these proposals move forward.
Nevertheless, employers should monitor these developments closely. A policy shift toward deregulation, increased competition, and individualized purchasing power could have lasting implications for employer-sponsored benefits, workforce planning, and compliance strategy.
As the health care landscape continues to evolve, staying informed and proactive will be critical for employers seeking to balance cost control, regulatory obligations, and employee needs.